Amgen Inc (AMGN): Share Repurchases
$0
Year ended 2025-12-31
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $200.00M | n/a | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $6.36B | +27.8% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $4.97B | +42.7% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $3.49B | -54.7% | 2023-02-09, From 2020-01-01 |
| 2019-12-31 | $7.70B | -56.7% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $17.79B | +463.1% | 2021-02-09, From 2018-01-01 |
| 2017-12-31 | $3.16B | +6.6% | 2020-02-12, From 2017-01-01 |
| 2016-12-31 | $2.96B | +58.8% | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | $1.87B | n/m | 2018-02-13, From 2015-01-01 |
| 2014-12-31 | $138.00M | -83.4% | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | $832.00M | -81.9% | 2016-02-16, From 2013-01-01 |
| 2012-12-31 | $4.61B | -44.6% | 2015-02-19, From 2012-01-01 |
| 2011-12-31 | $8.31B | +119.6% | 2014-02-24, From 2011-01-01 |
| 2010-12-31 | $3.79B | +18.0% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $3.21B | +41.4% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $2.27B | -55.5% | 2011-02-25, From 2008-01-01 |
| 2007-12-31 | $5.10B | n/a | 2010-03-01, From 2007-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Amgen Inc (AMGN) | 2025-12-31 | $0 | -100.0% |
| Gilead Sciences, Inc. (GILD) | 2025-12-31 | $1.92B | +67.1% |
| Biogen Inc. (BIIB) | 2024-12-31 | $0 | n/a |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $167.70M | -44.1% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $947.51M | +45.3% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $280.09M | -4.1% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $2.00M | n/a |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $342.37M | +36.9% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $41.67M | -84.9% |
Compare AMGN, GILD, BIIB, NBIX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗